Live from the NIH registry
Studies recruiting near Tucson right now
Top 25 of 474 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
Carpal Arch Space Augmentation (CASA) Clinical Trial
Carpal Tunnel Syndrome
N/A
Interventional 116 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Tucson, Arizona (5.4 mi)
· Sponsor: Sameek Roychowdhury
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
The University of Arizona Cancer Center - North Campus — Tucson, Arizona (5.4 mi)
· Sponsor: Eli Lilly and Company
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
HER2/Neu+ Uterine Serous Carcinoma
Phase 2
Interventional 50 participants sought
University of Arizona Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: Yale University
Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep
Insomnia, Primary
N/A
Interventional 20 participants sought
University of Arizona Psychiatry Department — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
Liver Fibrosis, Hepatic Cirrhosis
Phase 2
Interventional 104 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
Southern Arizona VA Health Care System, Tucson, AZ — Tucson, Arizona (5.4 mi)
· Sponsor: VA Office of Research and Development
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Alabama at Birmingham
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site - 7067 — Tucson, Arizona (5.4 mi)
· Sponsor: Galderma R&D
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Del Sol Research Management - Tucson East — Tucson, Arizona (5.4 mi)
· Sponsor: Crystalys Therapeutics
Enhancing Language Function in Aphasia
Aphasia, Acquired, Language Disorders
N/A
Interventional 30 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Tucson Cystic Fibrosis Center — Tucson, Arizona (5.4 mi)
· Sponsor: Nicole Hamblett
Methadone Patient Access to Collaborative Treatment
Opioid Use Disorder, Staff
N/A
Interventional 1,080 participants sought
University of Arizona College of Nursing — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Tucson, Arizona (5.4 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
Hypknowledge Nationwide Sleep Extension
Short Sleep Duration
N/A
Interventional 1,038 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Duke University
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
Banner - University Medical Group — Tucson, Arizona (5.4 mi)
· Sponsor: Uppsala University
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group